Published in Mol Pharmacol on June 01, 1999
Zinc transporter ZIP8 (SLC39A8) and zinc influence IFN-gamma expression in activated human T cells. J Leukoc Biol (2009) 1.50
Inhibition of human insulin gene transcription by peroxisome proliferator-activated receptor gamma and thiazolidinedione oral antidiabetic drugs. Br J Pharmacol (2009) 0.83
Regulation of human insulin gene transcription by the immunosuppressive drugs cyclosporin A and tacrolimus at concentrations that inhibit calcineurin activity and involving the transcription factor CREB. Naunyn Schmiedebergs Arch Pharmacol (2003) 0.80
The immunosuppressive drugs cyclosporin A and tacrolimus inhibit membrane depolarization-induced CREB transcriptional activity at the coactivator level. Br J Pharmacol (2005) 0.79
Differential Antitumoral Properties and Renal-Associated Tissue Damage Induced by Tacrolimus and Mammalian Target of Rapamycin Inhibitors in Hepatocarcinoma: In Vitro and In Vivo Studies. PLoS One (2016) 0.75
Diabetes-associated sustained activation of the transcription factor nuclear factor-kappaB. Diabetes (2001) 3.83
NF-kappaB is activated and promotes cell death in focal cerebral ischemia. Nat Med (1999) 2.96
Neuroprotective effect of granulocyte colony-stimulating factor after focal cerebral ischemia. Stroke (2003) 2.44
NF-kappaB signaling in cerebral ischemia. Neuroscience (2008) 1.88
Asthma experience in an occupational and environmental medicine clinic. Low-dose reactive airways dysfunction syndrome. J Occup Med (1994) 1.74
Intravenous brain-derived neurotrophic factor reduces infarct size and counterregulates Bax and Bcl-2 expression after temporary focal cerebral ischemia. Stroke (2000) 1.55
[Cerebrotendinous xanthomatosis, a treatable metabolic disorder]. Nervenarzt (2002) 1.39
Alpha-cell-specific expression of the glucagon gene is conferred to the glucagon promoter element by the interactions of DNA-binding proteins. Mol Cell Biol (1988) 1.35
The influence of carbohydrate gelling agents on rat intestinal transport of monosaccharides and neutral amino acids in vitro. Clin Sci (Lond) (1980) 1.25
Cerebrovascular manifestations of Takayasu arteritis in Europe. Rheumatology (Oxford) (2005) 1.11
Induction of interleukin-6 by depolarization of neurons. J Neurosci (2000) 1.10
[Fumaric acid or dimethyl fumarate?]. Nervenarzt (2015) 1.08
Distinct properties of the cAMP-responsive element of the rat insulin I gene. J Biol Chem (1994) 1.01
Acute inhibition of TAK1 protects against neuronal death in cerebral ischemia. Cell Death Differ (2011) 0.98
Involvement of the Ca(2+)-dependent phosphatase calcineurin in gene transcription that is stimulated by cAMP through cAMP response elements. J Biol Chem (1995) 0.96
Inhibition by antidepressant drugs of cyclic AMP response element-binding protein/cyclic AMP response element-directed gene transcription. Mol Pharmacol (1995) 0.96
Granzyme-b is involved in mediating post-ischemic neuronal death during focal cerebral ischemia in rat model. Neuroscience (2009) 0.96
Paracetamol as a test drug to determine glucuronide formation in man. Effects of inducers and of smoking. Eur J Clin Pharmacol (1987) 0.95
Heterodimeric Pbx-Prep1 homeodomain protein binding to the glucagon gene restricting transcription in a cell type-dependent manner. J Biol Chem (2000) 0.94
Inhibition of cAMP-responsive element-mediated gene transcription by cyclosporin A and FK506 after membrane depolarization. J Biol Chem (1993) 0.94
Inhibition of MafA transcriptional activity and human insulin gene transcription by interleukin-1beta and mitogen-activated protein kinase kinase kinase in pancreatic islet beta cells. Diabetologia (2007) 0.94
Gene-specific transcriptional activity of the insulin cAMP-responsive element is conferred by NF-Y in combination with cAMP response element-binding protein. J Biol Chem (1998) 0.93
Inhibition of CREB- and cAMP response element-mediated gene transcription by the immunosuppressive drugs cyclosporin A and FK506 in T cells. Naunyn Schmiedebergs Arch Pharmacol (1997) 0.93
Membrane depolarization and calcium influx induce glucagon gene transcription in pancreatic islet cells through the cyclic AMP-responsive element. J Biol Chem (1993) 0.91
Cerebellar ataxia after repeated hypoglycemia. Eur J Neurol (2002) 0.91
Bilateral facial palsy: Epstein-Barr virus, not Lyme disease. Eur J Neurol (2006) 0.89
Characterization of a novel calcium response element in the glucagon gene. J Biol Chem (1999) 0.88
Characterization of a novel protein kinase C response element in the glucagon gene. Mol Cell Biol (1997) 0.88
Expression of the kcnk3 potassium channel gene lessens the injury from cerebral ischemia, most likely by a general influence on blood pressure. Neuroscience (2010) 0.88
The ICAM-1 E469K gene polymorphism is a risk factor for spontaneous cervical artery dissection. Neurology (2006) 0.87
Inhibition of membrane depolarisation-induced transcriptional activity of cyclic AMP response element binding protein (CREB) by the dual-leucine-zipper-bearing kinase in a pancreatic islet beta cell line. Diabetologia (2005) 0.86
Tissue-specific transcriptional activity of a pancreatic islet cell-specific enhancer sequence/Pax6-binding site determined in normal adult tissues in vivo using transgenic mice. Mol Endocrinol (1999) 0.86
Role of vasopressin in the ACTH response to isoprenaline. Eur J Pharmacol (1982) 0.86
The immunosuppressive drugs cyclosporin A and FK506 inhibit calcineurin phosphatase activity and gene transcription mediated through the cAMP-responsive element in a nonimmune cell line. Naunyn Schmiedebergs Arch Pharmacol (1993) 0.85
Effect of isoprenaline and trimethidinium on the plasma vasopressin concentration in conscious rats. Arch Int Pharmacodyn Ther (1980) 0.85
Effects of a kappa-opioid agonist on adrenocorticotropic and diuretic function in man. Horm Metab Res (1986) 0.84
On the mechanism of the vasopressin-induced inhibition of renin release. Horm Metab Res (1982) 0.83
Normal pathways for glucuronidation, sulphation and oxidation of paracetamol in Gilbert's syndrome. Eur J Clin Invest (1987) 0.83
Adrenocorticotropin and beta-endorphin release from rat adenohypophysis in vitro: inhibition by prostaglandin E2 formed locally in response to vasopressin and corticotropin-releasing factor. Endocrinology (1984) 0.83
Insulin responsiveness of the glucagon gene conferred by interactions between proximal promoter and more distal enhancer-like elements involving the paired-domain transcription factor Pax6. J Biol Chem (2000) 0.83
Inhibition of human insulin gene transcription by peroxisome proliferator-activated receptor gamma and thiazolidinedione oral antidiabetic drugs. Br J Pharmacol (2009) 0.83
Evidence for the involvement of a GABA-mediated inhibition in the hypovolaemia-induced vasopressin release. Pflugers Arch (1980) 0.83
Calcium-mobilizing insulin secretagogues stimulate transcription that is directed by the cyclic adenosine 3',5'-monophosphate/calcium response element in a pancreatic islet beta-cell line. Endocrinology (1996) 0.83
A transgenic approach to identify thyroxine transporter-expressing structures in brain development. J Neuroendocrinol (2011) 0.82
Loss of insulin-induced inhibition of glucagon gene transcription in hamster pancreatic islet alpha cells by long-term insulin exposure. Diabetologia (2008) 0.82
The hepatitis B pX protein promotes dimerization and DNA binding of cellular basic region/leucine zipper proteins by targeting the conserved basic region. J Biol Chem (1999) 0.81
Evidence for inhibition by beta-endorphin of vasopressin release during foot shock-induced stress in the rat. Neuroendocrinology (1982) 0.81
Naloxone promotes stimulus-evoked vasopressin release in vivo. Eur J Pharmacol (1980) 0.81
Identification and expression of a novel isoform of cAMP response element modulator in the human heart. FASEB J (1998) 0.81
In vitro CRF activity of vasopressin analogs is not related to pressor activity. Eur J Pharmacol (1983) 0.81
Top concentrations of dynorphin-like immunoreactivity in fractions of rat anterior pituitary cells enriched in gonadotrophs. Life Sci (1986) 0.81
Vasopressin and beta-endorphin release after osmotic and non-osmotic stimuli: effect of naloxone and dexamethasone. Eur J Pharmacol (1982) 0.81
GRF elevates cytosolic free calcium concentration in rat anterior pituitary cells. Am J Physiol (1987) 0.81
Effect of transection of subfornical organ efferent projections on vasopressin release induced by angiotensin or isoprenaline in the rat. Brain Res (1982) 0.80
Cholecystokinin-like immunoreactivity of rat medial basal hypothalamus: investigations on a possible hypophysiotropic function. Neuroendocrinology (1983) 0.80
The effect of naloxone on vasopressin release from rat neurohypophysis incubated in vitro. J Physiol (1983) 0.80
Release of dynorphin-like immunoreactivity of rat neurohypophysis in comparison to vasopressin after various stimuli in vitro and in vivo. Neurosci Lett (1982) 0.79
A new class of inhibitors for in vitro small intestinal transport of sugars and amino acids in the rat. Biochim Biophys Acta (1983) 0.79
In vitro inhibition of rat intestinal surface hydrolysis of disaccharides and dipeptides by guaran. Digestion (1981) 0.79
Effect of human growth hormone-releasing hormone on the release of dynorphin-like immunoreactivity, luteinizing hormone, and follicle-stimulating hormone from rat adenohypophysis in vitro. Endocrinology (1987) 0.79
[Histological, histochemical and statistical investigations on length and distribution of mitochondria in segmented peripheral nerve fibers and their Schwann cells of the N. intercostalis in Bos taurus]. Acta Histochem (1964) 0.79
Potassium depolarization elevates cytosolic free calcium concentration in rat anterior pituitary cells through 1,4-dihydropyridine-sensitive, omega-conotoxin-insensitive calcium channels. Endocrinology (1988) 0.79
In vitro adrenocorticotropin/beta-endorphin-releasing activity of vasopressin analogs is related neither to pressor nor to antidiuretic activity. Endocrinology (1984) 0.79
Something old, something new and something very old: drugs for treating type 2 diabetes. Br J Pharmacol (2014) 0.79
Long-term feeding of unavailable carbohydrate gelling agents. Influence of dietary concentration and microbiological degradation on adaptive responses in the rat. Am J Clin Nutr (1981) 0.78
Stimulation of adrenocorticotropin/beta-endorphin release by synthetic ovine corticotropin-releasing factor in vitro. Enhancement by various vasopressin analogs. Neuroendocrinology (1984) 0.78
Vasopressin stimulates release of beta-lipotropin and beta-endorphin in conscious rats as measured by radioimmunoassay of unextracted plasma. Naunyn Schmiedebergs Arch Pharmacol (1981) 0.78
Effect of prostaglandin E2 on ACTH and beta-endorphin release from rat adenohypophysis in vitro after secretagogues which can mimic various first or second messengers. Naunyn Schmiedebergs Arch Pharmacol (1986) 0.78
Influence of melatonin on free radical-induced changes in rat pancreatic beta-cells in vitro. J Pineal Res (2000) 0.78
Nuclear factor-kappaB activation is not involved in a MPTP model of Parkinson's disease. Neuroreport (2001) 0.78
Clinical and genetic variability of oculodentodigital dysplasia. Clin Genet (2006) 0.78
Stimulation by melittin of adrenocorticotropin and beta-endorphin release from rat adenohypophysis in vitro. Prostaglandins (1987) 0.78
Role of the renin-angiotensin system in isoprenaline-induced vasopressin release. J Cardiovasc Pharmacol (1981) 0.77
Effect of various blockers of arachidonic acid metabolism on release of beta-endorphin- and adrenocorticotropin-like immunoreactivity induced by phospholipase A2 from rat adenohypophysis in vitro. Neuroendocrinology (1986) 0.77
Foot shock stress-induced release of vasopressin in adenohypophysectomized and hypophysectomized rats. Endocrinology (1985) 0.77